MultiBiotic

CLINICAL TRIAL

The safety and tolerability of a multi-species probiotic formulation in chemotherapy-induced intestinal mucositis/diarrhoea: an exploratory end-point pilot study

FORMULATION

MultibioticTM is a multi-species probiotic formulation consisting of lactobacilli and bifidobacteria predominately, that has been laboratory and clinically evaluated to improve the stability of the intestinal microbial cohort, especially during and after the administration of pharmaceutical medicines such as antibiotics, proton pump inhibitors, analgesic medications and other.

HREC

National Institute of Integrative Medicine (NIIM) EC00436

DATE of HREC approval

07/12/2017

HREC Reference number

NIIM HREC | 0043E_2017

CTN

TBA

STUDY SITE

Northern Cancer Institute, 38 Pacific Hwy, St Leonards NSW 2065

ANZCTR

ACTRN12618000927224

STATUS

Recruiting January 2019